Strategic Financial Services’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,090
| Closed | -$242K | – | 139 |
|
|
2021
Q2 | $242K | Sell |
1,090
-2,700
| -71% | -$599K | 0.02% | 130 |
|
|
2021
Q1 | $501K | Hold |
3,790
| – | – | 0.04% | 92 |
|
|
2020
Q4 | $656K | Hold |
3,790
| – | – | 0.06% | 86 |
|
|
2020
Q3 | $422K | Hold |
3,790
| – | – | 0.04% | 93 |
|
|
2020
Q2 | $225K | Sell |
3,790
-1,250
| -25% | -$74.2K | 0.03% | 120 |
|
|
2020
Q1 | $339K | Buy |
5,040
+1,290
| +34% | +$86.8K | 0.05% | 100 |
|
|
2019
Q4 | $316K | Hold |
3,750
| – | – | 0.04% | 121 |
|
|
2019
Q3 | $280K | Sell |
3,750
-550
| -13% | -$41.1K | 0.04% | 123 |
|
|
2019
Q2 | $272K | Hold |
4,300
| – | – | 0.04% | 122 |
|
|
2019
Q1 | $207K | Buy |
+4,300
| New | +$207K | 0.03% | 127 |
|
|
2018
Q4 | – | Sell |
-5,000
| Closed | -$262K | – | 140 |
|
|
2018
Q3 | $262K | Buy |
+5,000
| New | +$262K | 0.04% | 111 |
|